AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Mar 9, 2022. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 194
- −15 vs. Q2 2021
- Portfolio value
- $393.5M
- +$25.3M (+6.9%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| iShares Tr464288588 | MBS ETF | 1,310,000 | $141.7M | 36.0% | +100,000+8.3% | Added | – |
| Vanguard Mortgage-Backed Securities ETF92206C771 | ETF | 1,895,000 | $101.0M | 25.7% | +190,000+11.1% | Added | – |
| INVHInvitation Homes Inc. | COM | 854,144 | $32.7M | 8.3% | 00.0% | Unchanged | History |
| AMHAmerican Homes 4 Rent | CL A | 806,924 | $30.8M | 7.8% | 00.0% | Unchanged | History |
| RITMRithm Capital Corp. | REIT | 245,158 | $2.70M | 0.7% | 00.0% | Unchanged | History |
| iShares Tr464287457 | 1 3 YR TREAS BD | 23,625 | $2.04M | 0.5% | +8,565+56.9% | Added | – |
| STXSStereotaxis, Inc. | COM NEW | 350,000 | $1.88M | 0.5% | +25,000+7.7% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 10,250 | $1.86M | 0.5% | +3,000+41.4% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 1,750 | $1.74M | 0.4% | −250−12.5% | Reduced | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 29,500 | $1.55M | 0.4% | +8,000+37.2% | Added | History |
| AZTAAzenta, Inc. | COM | 15,000 | $1.53M | 0.4% | 00.0% | Unchanged | History |
| SNPSSynopsys Inc | COM | 5,000 | $1.50M | 0.4% | −500−9.1% | Reduced | History |
| OMCLOmnicell, Inc. | COM | 10,000 | $1.48M | 0.4% | 00.0% | Unchanged | History |
| AVAVAeroVironment Inc | COM | 15,000 | $1.29M | 0.3% | 00.0% | Unchanged | History |
| AMEAmetek Inc | COM | 10,000 | $1.24M | 0.3% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 73,500 | $1.22M | 0.3% | +60,000+444.4% | Added | History |
| Morphosys AG617760202 | SPONSORED ADS | 101,000 | $1.19M | 0.3% | +55,500+122.0% | Added | – |
| ALNTAllient Inc | COM | 37,500 | $1.17M | 0.3% | 00.0% | Unchanged | History |
| OYSTOyster Point Pharma, Inc. | COM | 98,500 | $1.17M | 0.3% | +62,000+169.9% | Added | History |
| NOVTNovanta Inc | COM | 7,500 | $1.16M | 0.3% | 00.0% | Unchanged | History |
| MCRBSeres Therapeutics, Inc. | COM | 165,500 | $1.15M | 0.3% | +165,500 | New | History |
| COGTCogent Biosciences, Inc. | COM | 134,475 | $1.13M | 0.3% | +11,975+9.8% | Added | History |
| EFCEllington Financial Inc. | COM | 60,283 | $1.10M | 0.3% | +28,283+88.4% | Added | History |
| BTAIQBioXcel Therapeutics, Inc. | COM | 35,000 | $1.06M | 0.3% | +10,000+40.0% | Added | History |
| INCYIncyte Corp | COM | 15,250 | $1.05M | 0.3% | +11,250+281.3% | Added | History |
| VUZIVuzix Corp | COM NEW | 100,000 | $1.05M | 0.3% | +100,000 | New | History |
| PBYIPuma Biotechnology, Inc. | COM | 148,500 | $1.04M | 0.3% | +108,500+271.3% | Added | History |
| CLPTClearPoint Neuro, Inc. | COM | 57,500 | $1.02M | 0.3% | +7,500+15.0% | Added | History |
| ARAYAccuray Inc | COM | 250,000 | $988.0K | 0.3% | +15,000+6.4% | Added | History |
| ZGNXZogenix, Inc. | COM NEW | 65,000 | $987.0K | 0.3% | +15,000+30.0% | Added | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 16,500 | $983.0K | 0.2% | +9,000+120.0% | Added | History |
| MFAMfa Financial, Inc. | COM | 214,436 | $980.0K | 0.2% | +68,277+46.7% | Added | History |
| TCRRTCR2 Therapeutics Inc. | COM | 113,000 | $962.0K | 0.2% | +72,000+175.6% | Added | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 54,500 | $957.0K | 0.2% | +24,500+81.7% | Added | – |
| COOPMaverick Merger Sub 2, LLC | COM | 22,794 | $938.0K | 0.2% | +3,655+19.1% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 17,000 | $918.0K | 0.2% | −8,000−32.0% | Reduced | History |
| ACRSAclaris Therapeutics, Inc. | COM | 51,000 | $918.0K | 0.2% | +14,000+37.8% | Added | History |
| CYBECyberoptics Corp | COM | 25,000 | $890.0K | 0.2% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 110,000 | $875.0K | 0.2% | +17,500+18.9% | Added | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 35,500 | $848.0K | 0.2% | +22,000+163.0% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 9,000 | $832.0K | 0.2% | −5,000−35.7% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 11,500 | $803.0K | 0.2% | −300−2.5% | Reduced | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 136,000 | $792.0K | 0.2% | +54,500+66.9% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 28,500 | $785.0K | 0.2% | +4,500+18.8% | Added | History |
| PRCTPROCEPT BioRobotics Corp | COM | 20,000 | $763.0K | 0.2% | +20,000 | New | History |
| Safehold Inc.45031U101 | COM | 30,279 | $759.0K | 0.2% | +25,995+606.8% | Added | – |
| AXSMAxsome Therapeutics, Inc. | COM | 23,000 | $758.0K | 0.2% | +11,000+91.7% | Added | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 30,500 | $752.0K | 0.2% | −3,000−9.0% | Reduced | History |
| VIRXViracta Therapeutics, Inc. | COM | 92,402 | $741.0K | 0.2% | 00.0% | Unchanged | History |
| MRKMerck & Co., Inc. | Stock | 9,750 | $732.0K | 0.2% | −2,250−18.8% | Reduced | History |
| COLLCollegium Pharmaceutical, Inc | COM | 37,000 | $730.0K | 0.2% | +28,000+311.1% | Added | History |
| PFSIPennyMac Financial Services, Inc. | COM | 11,699 | $715.0K | 0.2% | +10,348+766.0% | Added | History |
| MBOTMicrobot Medical Inc. | COM NEW | 100,000 | $703.0K | 0.2% | 00.0% | Unchanged | History |
| Adamas Trust, Inc.649604501 | COM PAR $.02 | 158,212 | $674.0K | 0.2% | +40,000+33.8% | Added | – |
| AHCOAdaptHealth Corp. | COMMON STOCK | 28,000 | $652.0K | 0.2% | +10,000+55.6% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 8,000 | $618.0K | 0.2% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 65,500 | $618.0K | 0.2% | +20,000+44.0% | Added | History |
| BLUEbluebird bio, Inc. | COM | 32,000 | $612.0K | 0.2% | −1,000−3.0% | Reduced | History |
| ONITOnity Group Inc. | COM NEW | 21,477 | $604.0K | 0.2% | 00.0% | Unchanged | History |
| RWTRedwood Trust Inc | COM | 45,148 | $582.0K | 0.1% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 71,500 | $566.0K | 0.1% | 00.0% | Unchanged | History |
| NNDMNano Dimension Ltd. | SPONSORD ADS NEW | 100,000 | $564.0K | 0.1% | −35,000−25.9% | Reduced | History |
| CHRSCoherus Oncology, Inc. | COM | 35,000 | $562.0K | 0.1% | −16,500−32.0% | Reduced | History |
| LIDRAEye, Inc. | CLASS A COM | 100,000 | $547.0K | 0.1% | +100,000 | New | History |
| AERIAerie Pharmaceuticals Inc | COM | 47,500 | $542.0K | 0.1% | +47,500 | New | History |
| PMTPennyMac Mortgage Investment Trust | COM | 26,764 | $527.0K | 0.1% | 00.0% | Unchanged | History |
| MTGMgic Investment Corp | COM | 33,775 | $505.0K | 0.1% | 00.0% | Unchanged | History |
| STROSutro Biopharma, Inc. | COM | 26,000 | $491.0K | 0.1% | −1,000−3.7% | Reduced | History |
| EXELExelixis, Inc. | COM | 23,000 | $486.0K | 0.1% | +2,500+12.2% | Added | History |
| Invesco Exch Traded FD Tr II46138G508 | SR LN ETF | 21,615 | $478.0K | 0.1% | +622+3.0% | Added | – |
| iShares Tr464288687 | PFD AND INCM SEC | 12,146 | $471.0K | 0.1% | +6,148+102.5% | Added | – |
| GYREGyre Therapeutics, Inc. | COM NEW | 114,000 | $469.0K | 0.1% | −68,500−37.5% | Reduced | History |
| State Street SPDR Bloomberg Convertible Securities ETF78464A359 | ETF | 5,477 | $467.0K | 0.1% | −53−1.0% | Reduced | – |
| iShares Tr46435G342 | MORTGE REL ETF | 12,885 | $466.0K | 0.1% | +286+2.3% | Added | – |
| PTCTPTC Therapeutics, Inc. | COM | 12,500 | $465.0K | 0.1% | +2,500+25.0% | Added | History |
| IMTXImmatics N.V. | SHS | 35,000 | $455.0K | 0.1% | −2,500−6.7% | Reduced | History |
| MSMorgan Stanley | Stock | 4,435 | $432.0K | 0.1% | +22+0.5% | Added | History |
| ICADIcad Inc | COM NEW | 40,000 | $430.0K | 0.1% | −5,000−11.1% | Reduced | History |
| Invesco Exchange Traded FD T46137V399 | S&P500 BUY WRT | 17,092 | $393.0K | 0.1% | −473−2.7% | Reduced | – |
| iShares Inc464286285 | JP MRGN EM HI BD | 8,709 | $386.0K | 0.1% | +226+2.7% | Added | – |
| Vanguard High Dividend Yield Index ETF921946406 | ETF | 3,708 | $383.0K | 0.1% | +72+2.0% | Added | – |
| SPDR Index Shs FDS78463X772 | ST S&P INTL ETF | 9,893 | $376.0K | 0.1% | +285+3.0% | Added | – |
| BCELAtreca, Inc. | CL A COM | 60,000 | $374.0K | 0.1% | −6,500−9.8% | Reduced | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 68,500 | $354.0K | 0.1% | −51,500−42.9% | Reduced | History |
| EVMEaton Vance California Municipal Bond Fund | COM | 28,200 | $337.0K | 0.1% | +28,200 | New | History |
| ALLAllstate Corp | Stock | 2,616 | $333.0K | 0.1% | +24+0.9% | Added | History |
| EIMEaton Vance Municipal Bond Fund | COM | 24,600 | $329.0K | 0.1% | +24,600 | New | History |
| iShares Tr46434V407 | 0-5YR HI YL CP | 6,952 | $318.0K | 0.1% | +177+2.6% | Added | – |
| SPDR Series Trust78468R622 | ST BLOO HIGH ETF | 2,900 | $317.0K | 0.1% | +47+1.6% | Added | – |
| iShares Inc464286178 | US INTL HGH YLD | 6,305 | $316.0K | 0.1% | +205+3.4% | Added | – |
| PMOFranklin Municipal Opportunities Trust | SH BEN INT | 23,000 | $315.0K | 0.1% | +23,000 | New | History |
| iShares Tr464288281 | JPMORGAN USD EMG | 2,847 | $313.0K | 0.1% | −625−18.0% | Reduced | – |
| MORFMorphic Holding, Inc. | COM | 5,500 | $312.0K | 0.1% | 00.0% | Unchanged | History |
| LENLennar Corp | CL A | 3,184 | $298.0K | 0.1% | +10.0% | Added | History |
| PMMFranklin Managed Municipal Income Trust | COM | 35,000 | $292.0K | 0.1% | +35,000 | New | History |
| DBTXDecibel Therapeutics, Inc. | COM | 37,500 | $289.0K | 0.1% | −7,500−16.7% | Reduced | History |
| DHIHorton D R Inc | COM | 3,333 | $280.0K | 0.1% | 00.0% | Unchanged | History |
| CICigna Group | Stock | 1,346 | $269.0K | 0.1% | +2+0.1% | Added | History |
| TGTTarget Corp | Stock | 1,162 | $266.0K | 0.1% | +1+0.1% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 6,000 | $266.0K | 0.1% | +6,000 | New | History |
Sold out since Q2 2021 (29)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| OUSTOuster, Inc. | COM | 85,000 | $1.06M | 0.3% | History |
| TVTXTravere Therapeutics, Inc. | COM | 61,500 | $897.0K | 0.2% | History |
| ADCTADC Therapeutics SA | SHS | 26,000 | $633.0K | 0.2% | History |
| D8 Holdings CorpG2614K110 | SHS CL A | 55,000 | $548.0K | 0.1% | – |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 32,500 | $453.0K | 0.1% | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 25,000 | $324.0K | 0.1% | History |
| Titan Med Inc88830X819 | COM NEW | 150,000 | $257.0K | 0.1% | – |
| CIMChimera Investment Corp | COM NEW | 15,762 | $237.0K | 0.1% | History |
| iShares Tr46429B135 | INTL PFD STK ETF | 13,040 | $224.0K | 0.1% | – |
| KDMNKadmon Holdings, Inc. | COM | 45,500 | $176.0K | <0.1% | History |
| RVICRetail Value Inc. | COM | 7,787 | $169.0K | <0.1% | History |
| MAVPioneer Municipal High Income Advantage Fund, Inc. | COM | 13,500 | $167.0K | <0.1% | History |
| VanEck ETF Trust92189H409 | HIGH YLD MUNIETF | 2,445 | $156.0K | <0.1% | – |
| VanEck ETF Trust92189F387 | SHRT HGH YLD MUN | 6,105 | $155.0K | <0.1% | – |
| SPDR Series Trust78464A284 | ST NUVE HIGH ETF | 2,555 | $155.0K | <0.1% | – |
| BLEBlackRock Municipal Income Trust II | COM | 9,065 | $143.0K | <0.1% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 2,000 | $126.0K | <0.1% | History |
| iShares Inc464286400 | MSCI BRAZIL ETF | 2,936 | $119.0K | <0.1% | – |
| iShares Inc464286772 | MSCI STH KOR ETF | 1,241 | $116.0K | <0.1% | – |
| CHMICherry Hill Mortgage Investment Corp | COM | 10,977 | $108.0K | <0.1% | History |
| iShares Tr464287184 | CHINA LG-CAP ETF | 2,000 | $93.0K | <0.1% | – |
| iShares Inc464286640 | MSCI CHILE ETF | 2,774 | $80.0K | <0.1% | – |
| PFEPfizer Inc | Stock | 2,000 | $78.0K | <0.1% | History |
| ABBVAbbVie Inc. | Stock | 425 | $48.0K | <0.1% | History |
| TAKTakeda Pharmaceutical Co Ltd | ADR | 2,200 | $37.0K | <0.1% | History |
| iShares Tr46429B309 | MSCI INDONIA ETF | 1,783 | $36.0K | <0.1% | – |
| BFKBlackRock Municipal Income Trust | SH BEN INT | 1,900 | $29.0K | <0.1% | History |
| CYTCyteir Therapeutics, Inc. | COM | 1,000 | $21.0K | <0.1% | History |
| iShares Inc46434G814 | MSCI MLY ETF NEW | 199 | $5.00K | <0.1% | – |